CASI Pharmeceuticals

Press Releases

About Us

A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.

Learn More

Poster

Annual Meeting Presentation

Download →

Poster

Corporate Presentation - BIO International Convention

Download →

Poster

Clinical Safety and Efficacy of the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated, Locally Advanced or Metastatic Triple-Negative Breast Cancer

Download →